(Total Views: 206)
Posted On: 08/18/2020 3:01:58 AM
Post# of 36542
https://themalaysianreserve.com/2020/08/18/co...ajinomoto/
Bintai Kinden inks MoU with US firm to develop Covid-19 vaccine
Bintai Kinden Corp Bhd has inked a memorandum of understanding (MoU) with US-based Nugenerex Immuno-Oncology (Generex) to collaborate in the development of a Covid-19 vaccine. Generex, a subsidiary of Generex Biotechnology Corp, has developed their proprietary, patented li-Key immune system activation technology that holds promise for stopping pandemic viral outbreaks like that of Covid-19, Bintai Kinden said in an exchange filing yesterday. –by FARA AISYAH
Bintai Kinden inks MoU with US firm to develop Covid-19 vaccine
Bintai Kinden Corp Bhd has inked a memorandum of understanding (MoU) with US-based Nugenerex Immuno-Oncology (Generex) to collaborate in the development of a Covid-19 vaccine. Generex, a subsidiary of Generex Biotechnology Corp, has developed their proprietary, patented li-Key immune system activation technology that holds promise for stopping pandemic viral outbreaks like that of Covid-19, Bintai Kinden said in an exchange filing yesterday. –by FARA AISYAH
(0)
(0)Scroll down for more posts ▼
